Abstract WP17: Efficacy of Edaravone Dexborneol in Real-World Patients With Acute Ischemic Stroke Receiving Reperfusion Therapy

医学 依达拉奉 缺血性中风 冲程(发动机) 急性中风 再灌注治疗 心脏病学 内科学 缺血 组织纤溶酶原激活剂 机械工程 工程类
作者
Yingting Zuo,Gaoting Ma,Ran Mo,Yifan Wu,Shaoyuan Lei,Shujuan Meng,Yue Wu,Ziying Jiang,Lianmei Zhong
出处
期刊:Stroke [Lippincott Williams & Wilkins]
卷期号:56 (Suppl_1)
标识
DOI:10.1161/str.56.suppl_1.wp17
摘要

Background: Edaravone dexborneol is a multitarget brain cytoprotection composed of antioxidation and anti-inflammation. We aimed to assess the effect of edaravone dexborneol on functional outcome in patients with acute ischemic stroke receiving reperfusion therapy. Methods: This study was a post hoc analysis of the EXPAND (The Effectiveness and Safety of Edaravone Dexborneol in Acute Ischemic Stroke) study, which was a prospective, multicenter cohort study that enrolled 4684 patients from January 2023 to October 2023 at 72 centers in China. Of these 4 684 patients, 1 035 patients aged 18 years or older, had a clinically diagnosed acute ischemic stroke symptom from onset to admission within 14 days, received reperfusion therapy (either intravenous treatment or endovascular treatment or intravenous bridging endovascular treatment), modified Rankin Scale (mRS) score of 0-1 prior to onset, and the ability to provide informed consents. Patients were divided into two groups (edaravone dexborneol or no edaravone dexborneol). The primary outcome was the proportion of patients with a favorable outcome based on 90-day mRS that was adjusted for baseline stroke severity (an mRS socre of 0 in patients with baseline National Institutes of Health Stroke Scale [NIHSS] score of 0 to 7; an mRS of 0 to 1 in patients with a baseline NIHSS score of 8 to 14; and an mRS score of 0 to 2 in patients with a baseline NIHSS score greater than or equal to 15). The secondary outcome was the score on the mRS score (range, 0 to 6 points, with higher scores indicating greater disability) at 90 days. Data were analyzed using multivariate regression after adjusting for the potential confounding factors. Results: Of 1 035 patients (of whom 706 were men [68.2%]; median [interquartile] age, 65 [56-72] years) were recruited into the study, 629 were treated with edaravone dexborneol and 406 were not. A 90-day favorable functional outcome occurred in 301 patients (47.8%) in edaravone dexborneol group and 159 patients (39.2%) in no edaravone dexborneol group (adjusted odds ratio, 1.38; 95% CI, 1.06-1.80). The distribution of the mRS score showed that good functional outcome favoring the edaravone dexborneol group (adjusted common odds ratio, 1.30; 95% CI, 1.02-1.64). Conclusions: For patients with acute ischemic stroke receiving reperfusion therapy, edaravone dexborneol use was associated with a higher proportion of patients achieving a favorable functional outcome compared with no use.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
shocwk发布了新的文献求助10
刚刚
lyl发布了新的文献求助30
1秒前
Owen的应助被天天采纳,获得10
1秒前
小蘑菇的应助被天天采纳,获得10
1秒前
传奇3的应助被天天采纳,获得10
1秒前
Jasper的应助被积极的含灵采纳,获得10
1秒前
CodeCraft的应助被天天采纳,获得10
1秒前
可爱的函函的应助被天天采纳,获得10
1秒前
fangmeiyuan完成签到,获得积分10
2秒前
斯文败类的应助被天天采纳,获得10
2秒前
李爱国的应助被天天采纳,获得10
2秒前
天天快乐的应助被天天采纳,获得10
2秒前
完美世界的应助被天天采纳,获得10
2秒前
JamesPei的应助被天天采纳,获得10
2秒前
zhi完成签到,获得积分10
4秒前
carrot完成签到,获得积分10
5秒前
刘刘发布了新的文献求助10
6秒前
nunl发布了新的文献求助10
6秒前
岳雨萌完成签到,获得积分20
6秒前
墨雪归青完成签到,获得积分10
7秒前
金常常完成签到,获得积分10
8秒前
8秒前
momo完成签到 ,获得积分10
11秒前
11秒前
烟花的应助被zzz采纳,获得10
12秒前
NexusExplorer的应助被费洛蒙漩涡采纳,获得10
12秒前
沉静俊驰完成签到,获得积分10
13秒前
14秒前
奋斗者完成签到,获得积分10
14秒前
15秒前
打打的应助被科研通管家采纳,获得10
16秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
16秒前
共享精神的应助被科研通管家采纳,获得10
16秒前
我是老大的应助被ff采纳,获得10
16秒前
木9发布了新的文献求助10
16秒前
小马甲的应助被科研通管家采纳,获得10
16秒前
李健的应助被科研通管家采纳,获得10
16秒前
超级无敌的应助被科研通管家采纳,获得10
16秒前
慕青的应助被科研通管家采纳,获得10
17秒前
zxqzxq完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8191314
求助须知:如何正确求助?哪些是违规求助? 9578210
关于积分的说明 21857267
捐赠科研通 7790624
什么是DOI,文献DOI怎么找? 3436606
关于科研通互助平台的介绍 2560359
邀请新用户注册赠送积分活动 2483305